On 11/2/23, Pediatrix Medical Group Inc (NYSE: MD) stock suffered a major decline of -11.8%, closing at $9.89. Relative to the market the stock has been weak over the last nine months and has declined -16.6% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, MD is expected to continue to be a major Value Builder.
Pediatrix Medical Group has a current Value Trend Rating of D (Negative). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Pediatrix Medical Group has a slightly negative Appreciation Score of 40 and a slightly negative Power Rating of 33, leading to the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment